Abstract


 Continuous learning artificial intelligence as a medical device or as part of a medical device is a rapidly developing area – both in terms of technology development and determining how to regulate and evaluate these technologies.
 As of the writing of this report, no medical device enabled with continuous learning artificial intelligence has been authorized in Canada.
 Continuous learning artificial intelligence for health care may have a cascading effect on national and international level, including reshaping and shifting the role of regulators and health technology assessment agencies. The body of literature on the regulation, HTA, and ethical, social, and legal issues relating to the regulation and assessment of continuous learning AI is growing and changes can continue to be anticipated in this space.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call